Mitchell E. Levinson

All filings by Mitchell E. Levinson on record concern Pulse Biosciences, Inc., in the capacity of senior executive. In total, 54 filings cover trades dated from 14 September 2017 to 24 September 2024.

Purchases make up the whole of the open-market record (19 purchases, €208k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 35 share grants.

Half of the purchases are above €10k and half below. On 18 out of 18 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 30 September 2024, reports a share grant of €3,165 in Pulse Biosciences, Inc. The clock since the last published purchase (17 November 2023) now reads 1,087 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.